患有心力衰竭和减少喷射分数的患者中 mitra:来自 GALACTIC-HF 的见解
Misato Chimura1,2, Kieran F Docherty1, Pardeep S Jhund1
1British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
European journal of heart failure
|March 2, 2026
概括
中度额头 (MR) 影响近15%的心力衰竭患者减少喷射率 (HFrEF) 患者,并增加他们的心血管不良事件的风险. 对这些患者来说,透管门修复可能是一个选择.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
- 膜心脏疾病 膜心脏疾病
背景情况:
- 在患有心力衰竭和减少喷射率 (HFrEF) 的患者中,越来越多地发现了二次腹 (MR).
- 超导管修复技术正在成为HFrEF中中度至重度MR的潜在治疗方法.
- 了解HFrEF中MR的患病率和影响对于指导治疗策略至关重要.
研究的目的:
- 在GALACTIC-HF试验中,确定HFrEF患者中中度/严重MR的患病率.
- 评估MR与该患者群体的临床结果之间的关联.
- 评估MR患者是否有资格参加现有的跨导管修复试验.
主要方法:
- 在随机 GALACTIC-HF 试验中,对 7998 名 HFrEF 患者的基线数据进行分析.
- 根据MR严重程度对患者进行分类:没有,轻度和中度/重度.
- 统计分析以评估与MR严重程度相关的初级复合结果 (HF事件或心血管死亡).
主要成果:
- 15.3%的患者有中度MR;严重的MR是罕见的 (0.3%).
- 中度MR与初级复合结果的显著更高风险相关 (aHR 1.11;95% CI 1.01-1.23).
- 这种关联在不太严重的心力衰竭的患者中更为明显,并且没有受到omecamtiv mecarbil治疗的改变.
结论:
- 中度MR在HFrEF中普遍存在,并且与HF事件和心血管死亡风险增加有关.
- 很大一部分中度/重度MR患者符合跨导管修复试验的标准.
- 需要进一步的研究来优化HFrEF中MR的管理.
更多相关视频
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
11:13Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
相关概念视频
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...